Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.BMJ. 2005; 330: 625-633
- NT-ProBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality.J Cardiac Fail. 2005; 11: S3-S8
- Simple clinical criteria to determine the prognosis of heart failure.J Cardiovasc Pharmacol Ther. 2005; 10: 173-180
- Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure.Am J Med. 2004; 116: 466-473
- Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.J Am Coll Cardiol. 2006; 47: 583-586
- Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.J Am Coll Cardiol. 2004; 43: 635-641
- Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.Am J Cardiol. 2005; 96: 705-709
- Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.Arch Int Med. 2006; 166: 315-320